Mink Therapeutics Stock Price History
INKT Stock | USD 7.92 0.32 3.88% |
If you're considering investing in Mink Stock, it is important to understand the factors that can impact its price. As of today, the current price of Mink Therapeutics stands at 7.92, as last reported on the 20th of March, with the highest price reaching 8.65 and the lowest price hitting 7.80 during the day. Mink Therapeutics is very risky given 3 months investment horizon. Mink Therapeutics has Sharpe Ratio of 0.11, which conveys that the firm had a 0.11 % return per unit of risk over the last 3 months. We were able to collect data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.43% are justified by taking the suggested risk. Use Mink Therapeutics Mean Deviation of 7.65, downside deviation of 10.61, and Risk Adjusted Performance of 0.1087 to evaluate company specific risk that cannot be diversified away.
Mink Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Mink |
Sharpe Ratio = 0.112
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | INKT | |||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
12.8 actual daily | 96 96% of assets are less volatile |
Expected Return
1.43 actual daily | 28 72% of assets have higher returns |
Risk-Adjusted Return
0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Mink Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mink Therapeutics by adding it to a well-diversified portfolio.
Mink Therapeutics Stock Price History Chart
There are several ways to analyze Mink Stock price data. The simplest method is using a basic Mink candlestick price chart, which shows Mink Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | February 4, 2025 | 12.03 |
Lowest Price | December 23, 2024 | 4.91 |
Mink Therapeutics March 20, 2025 Stock Price Synopsis
Various analyses of Mink Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Mink Stock. It can be used to describe the percentage change in the price of Mink Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Mink Stock.Mink Therapeutics Price Action Indicator | (0.47) | |
Mink Therapeutics Price Daily Balance Of Power | (0.38) | |
Mink Therapeutics Price Rate Of Daily Change | 0.96 |
Mink Therapeutics March 20, 2025 Stock Price Analysis
Mink Stock Price History Data
The price series of Mink Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 7.12 with a coefficient of variation of 18.3. Under current investment horizon, the daily prices are spread out with arithmetic mean of 8.53. The median price for the last 90 days is 8.79. The company completed 1:10 stock split on 28th of January 2025.Open | High | Low | Close | Volume | ||
03/20/2025 | 7.80 | 8.65 | 7.80 | 7.92 | ||
03/19/2025 | 7.80 | 8.65 | 7.80 | 7.92 | 7,877 | |
03/18/2025 | 9.22 | 9.22 | 7.70 | 8.24 | 32,258 | |
03/17/2025 | 8.97 | 9.71 | 8.52 | 8.52 | 15,689 | |
03/14/2025 | 8.37 | 8.49 | 8.18 | 8.49 | 2,497 | |
03/13/2025 | 7.90 | 8.50 | 7.81 | 7.98 | 4,816 | |
03/12/2025 | 7.82 | 8.43 | 7.82 | 7.98 | 5,377 | |
03/11/2025 | 7.54 | 8.39 | 7.54 | 7.81 | 7,107 | |
03/10/2025 | 7.95 | 8.43 | 7.54 | 7.66 | 11,082 | |
03/07/2025 | 8.15 | 8.88 | 8.11 | 8.20 | 12,104 | |
03/06/2025 | 7.94 | 8.80 | 7.90 | 8.16 | 12,857 | |
03/05/2025 | 8.09 | 8.62 | 8.09 | 8.15 | 3,013 | |
03/04/2025 | 8.27 | 8.52 | 7.79 | 8.10 | 14,862 | |
03/03/2025 | 8.61 | 8.80 | 8.39 | 8.79 | 11,611 | |
02/28/2025 | 8.84 | 9.05 | 7.90 | 8.95 | 11,343 | |
02/27/2025 | 9.31 | 9.41 | 8.87 | 9.10 | 4,832 | |
02/26/2025 | 9.25 | 9.54 | 9.20 | 9.32 | 6,457 | |
02/25/2025 | 10.32 | 10.74 | 9.09 | 9.66 | 24,582 | |
02/24/2025 | 10.00 | 12.00 | 9.99 | 10.65 | 21,223 | |
02/21/2025 | 10.00 | 10.38 | 9.91 | 10.10 | 6,320 | |
02/20/2025 | 9.65 | 10.00 | 8.97 | 9.86 | 13,189 | |
02/19/2025 | 9.50 | 9.82 | 9.40 | 9.49 | 4,478 | |
02/18/2025 | 9.60 | 9.98 | 9.53 | 9.95 | 13,659 | |
02/14/2025 | 9.25 | 9.67 | 9.04 | 9.50 | 4,397 | |
02/13/2025 | 9.34 | 9.35 | 9.00 | 9.23 | 4,927 | |
02/12/2025 | 9.94 | 9.94 | 8.85 | 9.38 | 31,067 | |
02/11/2025 | 10.06 | 10.60 | 9.90 | 10.18 | 6,527 | |
02/10/2025 | 11.18 | 11.18 | 9.96 | 9.96 | 27,039 | |
02/07/2025 | 11.44 | 11.99 | 10.80 | 11.19 | 31,157 | |
02/06/2025 | 10.90 | 12.56 | 10.90 | 11.10 | 54,764 | |
02/05/2025 | 11.91 | 13.79 | 10.75 | 10.85 | 202,555 | |
02/04/2025 | 7.95 | 13.61 | 7.32 | 12.03 | 350,859 | |
02/03/2025 | 8.93 | 9.45 | 7.86 | 7.86 | 40,100 | |
01/31/2025 | 6.95 | 9.20 | 6.92 | 9.16 | 84,922 | |
01/30/2025 | 6.74 | 7.21 | 6.10 | 6.89 | 63,392 | |
01/29/2025 | 5.70 | 7.31 | 5.55 | 6.60 | 139,417 | |
01/28/2025 | 8.60 | 8.60 | 4.56 | 5.51 | 301,058 | |
01/27/2025 | 9.35 | 9.79 | 8.70 | 8.84 | 13,577 | |
01/24/2025 | 9.77 | 9.80 | 8.83 | 9.35 | 5,771 | |
01/23/2025 | 10.20 | 10.20 | 9.08 | 9.75 | 17,742 | |
01/22/2025 | 9.01 | 10.70 | 8.70 | 10.10 | 41,727 | |
01/21/2025 | 8.80 | 9.80 | 8.60 | 9.50 | 26,161 | |
01/17/2025 | 8.78 | 8.90 | 8.21 | 8.80 | 9,500 | |
01/16/2025 | 8.69 | 8.90 | 8.30 | 8.32 | 6,968 | |
01/15/2025 | 8.70 | 9.05 | 8.27 | 8.70 | 8,513 | |
01/14/2025 | 7.80 | 8.60 | 7.37 | 8.50 | 12,280 | |
01/13/2025 | 7.59 | 8.20 | 7.50 | 7.74 | 12,354 | |
01/10/2025 | 8.00 | 8.00 | 7.00 | 7.31 | 11,288 | |
01/08/2025 | 8.81 | 8.89 | 7.38 | 7.80 | 25,045 | |
01/07/2025 | 9.10 | 9.40 | 8.60 | 9.20 | 9,479 | |
01/06/2025 | 9.00 | 9.18 | 8.62 | 9.02 | 12,817 | |
01/03/2025 | 10.40 | 10.40 | 8.30 | 8.87 | 33,868 | |
01/02/2025 | 7.00 | 12.30 | 6.80 | 10.10 | 187,442 | |
12/31/2024 | 6.80 | 6.97 | 6.30 | 6.97 | 25,926 | |
12/30/2024 | 6.25 | 6.40 | 5.80 | 6.30 | 9,783 | |
12/27/2024 | 5.30 | 5.75 | 5.01 | 5.75 | 12,204 | |
12/26/2024 | 5.30 | 5.50 | 5.00 | 5.28 | 9,527 | |
12/24/2024 | 5.22 | 5.40 | 4.90 | 5.29 | 8,685 | |
12/23/2024 | 5.30 | 5.50 | 4.90 | 4.91 | 12,306 | |
12/20/2024 | 5.25 | 5.25 | 4.80 | 5.24 | 10,150 | |
12/19/2024 | 5.11 | 5.54 | 4.71 | 5.00 | 8,879 |
About Mink Therapeutics Stock history
Mink Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mink is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mink Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mink Therapeutics stock prices may prove useful in developing a viable investing in Mink Therapeutics
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T cell therapies to treat cancer and other immune-mediated diseases. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc. Mink Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 33 people.
Mink Therapeutics Stock Technical Analysis
Mink Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
All Next | Launch Module |
Mink Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Mink Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Mink Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mink to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1087 | |||
Jensen Alpha | 1.41 | |||
Total Risk Alpha | 2.51 | |||
Sortino Ratio | 0.1413 | |||
Treynor Ratio | (10.91) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Mink Stock Analysis
When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.